General Information of the Compound
Compound ID
CP0507613
Compound Name
1-[2-[2-[1-(3,4-dichlorophenyl)pyrazol-3-yl]oxyethoxy]ethyl]piperidine
    Show/Hide
Structure
Formula
C18H23Cl2N3O2
Molecular Weight
384.307
Canonical SMILES
Clc1ccc(cc1Cl)-n1ccc(OCCOCCN2CCCCC2)n1
    Show/Hide
InChI
InChI=1S/C18H23Cl2N3O2/c19-16-5-4-15(14-17(16)20)23-9-6-18(21-23)25-13-12-24-11-10-22-7-2-1-3-8-22/h4-6,9,14H,1-3,7-8,10-13H2
    Show/Hide
InChIKey
AILGBBRMXHWWAF-UHFFFAOYSA-N
Physicochemical Property
logP
4.0604
Rotatable Bonds
8
Heavy Atom Count
25
Polar Areas
39.52
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16730082
SID: 26688205
ChEMBL ID
CHEMBL2170207
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 36.8 nM
   TI
   LI
   LO
   TS